Drawing for ALROVEB

USPTO serial 78842387

ALROVEB

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
KAUFMAN, LAURIE R
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ALROVEB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nadine P. Flynn

NADINE P FLYNN BRISTOL-MYERS SQUIBB COMPANY345 PARK AVENEW YORK, NY 10154-0004UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals and immunosuppressants; pharmaceutical antibodies for human use; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agentsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 11, 2007MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Jul 11, 2007ABN5ABANDONMENT - AFTER PUBLICATION—
Jul 11, 2007EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jun 26, 2007NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 3, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 14, 2007NPUBNOTICE OF PUBLICATION—
Feb 17, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 17, 2007ALIEASSIGNED TO LIE—
Jan 12, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 11, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 11, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 11, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 30, 2006CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 29, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 24, 2006DOCKASSIGNED TO EXAMINER—
Mar 24, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance